Head and Neck Cancer
Head and neck cancer is a collective term for cancers that develop in areas such as the mouth, throat, larynx, nose, sinuses, or salivary glands, with symptoms varying by location and including issues like persistent mouth ulcers, voice changes, and difficulty swallowing; tobacco and alcohol use are the two most significant risk factors.
Health Outcomes
- Activated p53/BAX-Mediated DNA Damage Response
- Adjunctive Treatment for Jaw Osteomyelitis
- Cancer Treatment Support
- Delayed Oral Mucositis Onset
- Improved Chemotherapy Efficacy
- Improved Objective Response Rate
- Improved Oncolytic Virotherapy Efficacy
- Improved Oral Mucositis
- Improved Oral Mucositis Healing
- Improved Overall Survival
- Improved Progression-free Survival
- Improved Response to Immune Checkpoint Inhibitor Therapy
- Improved Response to PD-1 Immunotherapy
- Increased Flavor-Related Free Amino Acids
- Increased Intratumoral CD8+ T-cell Expansion
- Modulated Oral Cancer-Related Signaling
- No Improvement in Objective Cancer Treatment Response
- Reduced Cancer-Related Inflammation
- Reduced Chemotherapy Side Effects
- Reduced Dysgeusia
- Reduced Dysphagia
- Reduced Gastrointestinal Toxicity
- Reduced Incidence of Oral Mucositis
- Reduced Mucositis
- Reduced Mucositis Severity
- Reduced Oral Mucositis Incidence
- Reduced Oral Mucositis Severity
- Reduced Oral Mucositis Symptoms
- Reduced Radiation-Induced Dermatitis Severity
- Reduced Radiation-Induced Oral Mucositis
- Reduced Severe Oral Mucositis Duration
- Reduced Tumor Downstaging
- Reduced Xerostomia